Skip to main content
SpringerLink
Log in

Therapiestrategien beim primär metastasierten Rektumkarzinom

  • Chapter
  • First Online:
Moderne Chirurgie des Rektumkarzinoms

  • 3180 Accesses

Zusammenfassung

Das Vorliegen einer Fernmetastasierung zum Diagnosezeitpunkt bedeutet bei soliden Tumoren in der Regel ein Erkrankungsstadium mit sehr schlechter Prognose. Bei kolorektalen Karzinomen ergibt sich jedoch ein weites Spektrum möglicher Befallsmuster und Krankheitsverläufe, angefangen von einer limitierten Metastasierung eines Organes mit oft noch verhältnismäßig guter Prognose bis hin zur disseminierten Aussaat ohne Aussicht auf Heilung. Entscheidend für den individuellen Patienten ist es, ob eine komplette Resektion sowohl des Primärtumors als auch der Metastasen erreicht werden kann. Die dafür notwendigen diagnostischen Schritte, die daraus abzuleitenden Therapiestrategien und deren Abfolge sowie die erzielbaren Ergebnisse werden unter Fokussierung auf die chirurgische Behandlung in diesem Kapitel dargestellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D (2006) Improving respectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13:1271–1280

    Article  PubMed  Google Scholar 

  • Abdalla EK, Bauer TW, Chun YS, D’Angelica M, Kooby DA, Jarnagin WR (2013) Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford) 15:119–130

    Article  Google Scholar 

  • Adam R, Delvart V, Pascal G et al (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy. Ann Surg 240:644–658

    Article  PubMed Central  PubMed  Google Scholar 

  • Adam R, Aloia T, Lévi F et al (2007) Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol 25:4593–4602

    Article  CAS  PubMed  Google Scholar 

  • Alberts SR, Horvath WL, Sternfeld WC et al (2005) Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23:9243–9249

    Article  CAS  PubMed  Google Scholar 

  • Ayez N, Burger JWA, van der Pool AE et al (2013) Long-term results of the « livert first » approach in patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 56:281–287

    Article  PubMed  Google Scholar 

  • Benoist S, Brouquet A, Penna C et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24:3939–3945

    Article  PubMed  Google Scholar 

  • Bismuth H, Adam R, Lévi F et al (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–522

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006:1114–1123

    Article  Google Scholar 

  • Brouquet A, Mortenson MM, Vauthey JN et al (2010) Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 210:934–941

    Article  PubMed  Google Scholar 

  • Brouquet A, Vauthey JN, Contreras et al (2011) Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. J Am Coll Surg 213:62–69

    Article  PubMed  Google Scholar 

  • Brush J, Boyd K, Chappell F et al (2011) The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Health Technol Assess 15:1–192

    Article  CAS  PubMed  Google Scholar 

  • Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13:1261–1268

    Article  PubMed  Google Scholar 

  • de Haas RJ, Adam R, Wicherts DA et al (2010) Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg 97:1279–1289

    Article  PubMed  Google Scholar 

  • de Haas RJ, Wicherts DA, Andreani P et al (2011) Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg 253:1069–1079

    Article  PubMed  Google Scholar 

  • de Santibañes E, Clavien PA (2012) Playing Play-Doh to prevent postoperative liver failure: the ‚ALPPS“ approach. Ann Surg 255:415–417

    Article  PubMed  Google Scholar 

  • Esquivel J, Sticca R, Sugarbaker P et al (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol 14:128–133

    Article  CAS  PubMed  Google Scholar 

  • Folprecht G, Gruenberger T, Bechstein WO et al (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 11:38–47

    Article  CAS  PubMed  Google Scholar 

  • Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Analysis of 1001 consecutive cases. Ann Surg 230:309–321

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gervaz P, Rubbia-Brandt L, Andres A et al (2010) Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes. Ann Surg Oncol 17:2714–2719

    Article  PubMed  Google Scholar 

  • Homayounfar K, Bleckmann A, Conradi LC et al (2012) Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment. Int J Colorectal Dis 27:1259–1267

    Article  Google Scholar 

  • Masi G, Loupakis F, Pollina L et al (2009) Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg 249:420–425

    Article  PubMed  Google Scholar 

  • Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD (2006) Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 93:872–878

    Article  CAS  PubMed  Google Scholar 

  • Min BS, Kim NK, Sohn SK, Cho CH, Lee KY, Baik SH (2008) Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma. J Surg Oncol 97:136–140

    Article  PubMed  Google Scholar 

  • Mitry E, Fields ALA, Bleiberg H et al (2008) Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 26:4906–4911

    Article  CAS  PubMed  Google Scholar 

  • Mulsow J, Merkel S, Agaimy A, Hohenberger W (2011) Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases. Br J Surg 98:1785–1791

    Article  CAS  PubMed  Google Scholar 

  • Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial. Lancet 371:1007–1016

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Nordlinger B, Van Cutsem E, Gruenberger T et al (2009) Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 20:985–992

    Article  CAS  PubMed  Google Scholar 

  • Nordlinger B, Sorbye H, Glimelius B et al (2012) EORTC liver metastases intergroup randomized phase III study 40983: Long-term survival results. J Clin Oncol 30 (suppl; abstr 3508)

    Google Scholar 

  • Oldhafer KJ, Lang H, Malagó M, Testa G, Broelsch CE (2001) Ex situ resection and resection of the in situ perfused liver: are there still indications? Chirurg 72:131–137

    Article  CAS  PubMed  Google Scholar 

  • Pfannschmidt J, Hoffmann H, Dienemann H (2010) Reported outcome factors for pulmonary resection in metastatic colorectal cancer. J Thorac Oncol 5(6 Suppl 2):172–178

    Article  Google Scholar 

  • Poston GJ, Adam R, Alberts S et al (2005) OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 23:7125–7134

    Article  PubMed  Google Scholar 

  • Poston G, Adam R, Vauthey JN (2006) Downstaging or downsizing: time for a new staging system in advanced colorectal cancer? J Clin Oncol 24:2702–2706

    Article  PubMed  Google Scholar 

  • Registry of Hepatic Metastases (1988) Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 155:278–288

    Google Scholar 

  • Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP (1991) Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110:13–29

    CAS  PubMed  Google Scholar 

  • Schnitzbauer AA, Lang SA, Goessmann H et al (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255:405–414

    Article  PubMed  Google Scholar 

  • Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94:982–999

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Slesser AA, Simillis C, Goldin R, Brown G, Mudan S, Tekkis PP (2013) A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases. Surg Oncol 22:36–47

    Article  CAS  PubMed  Google Scholar 

  • Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumors, 7. Aufl. John Wiley und Sons, New York

    Google Scholar 

  • Sorbye H, Mauer M, Gruenberger T et al (2012) Predictive factors for the benefit of preoperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). Ann Surg 255:534–539

    Article  PubMed  Google Scholar 

  • Souglakos J, Androulakis N, Syrigos K et al (2006) FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG). Br J Cancer 94:798–805

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Stelzner S, Hellmich G, Koch R, Ludwig K (2005) Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol 89:211–217

    Article  PubMed  Google Scholar 

  • Stelzner S, Hellmich G, Jackisch T, Ludwig K, Witzigmann H (2008) Selective surgical treatment of patients with rectal carcinoma and unresectable synchronous metastases based on response to preoperative chemotherapy. J Gastrointest Surg 12:1246–1250

    Article  PubMed  Google Scholar 

  • Sugarbaker PH, Ryan DP (2012) Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncol 13:e362–e369

    Article  PubMed  Google Scholar 

  • Taylor FG, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone. Ann Surg :711–719

    Google Scholar 

  • Tomlinson JS, Jarnagin WR, DeMatteo RP et al (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25:4575–4580

    Article  PubMed  Google Scholar 

  • van der Pool AE, Lalmahomed ZS, de Wilt JH, Eggermont AM, Ijzermans JN, Verhoef C (2010) Trends in treatment for synchronous colorectal liver metastases: differences in outcome before and after 2000. J Surg Oncol 102:413–418

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Allgemein- und Viszeralchirurgie, Krankenhaus Dresden-Friedrichstadt, Friedrichstraße 41, 01067, Dresden, Deutschland

    Sigmar Stelzner PD Dr. med. & Helmut Witzigmann Prof. Dr. med.

Authors
  1. Sigmar Stelzner PD Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helmut Witzigmann Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sigmar Stelzner PD Dr. med. .

Editor information

Editors and Affiliations

  1. Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany

    Martin E. Kreis

  2. Klinik für Allgemein- und Viszeralchirurgie, Vivantes Klinikum im Friedrichshain, Berlin, Germany

    Joachim Straßburg

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stelzner, S., Witzigmann, H. (2015). Therapiestrategien beim primär metastasierten Rektumkarzinom. In: Kreis, M., Straßburg, J. (eds) Moderne Chirurgie des Rektumkarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40390-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-40390-3_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-40389-7

  • Online ISBN: 978-3-642-40390-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation